Evaluation of atezolizumab (A), cobimetinib (C), and vemurafenib (V) in previously untreated patients with BRAFV600 mutation-positive advanced melanoma: Primary results from the phase 3 IMspire150 trial

Authors :: McArthur, A. Stroyakovskiy, Daniil Gogas, Helen Robert, Caroline Lewis, Karl Protsenko, Svetlana Pereira, Rodrigo and Eigentler, Thomas Rutkowski, Piotr Demidov, Lev and Manikhas, Georgy Moiseevich Yan, Yibing Huang, K. C. Uyei, Anne McNally, Virgina Gutzmer, Ralf Ascierto, Paolo
Publication Year :: 2020

Tools